Latest stories on BBIO
BridgeBio Wins FDA Priority Review for BBP-418 Therapy
TipRanks77 · bullishproduct/pr
BridgeBio gains as muscular dystrophy therapy gets FDA priority review
Seeking Alpha77 · bullishproduct/pr
BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9 | BBIO Stock News
StockTitan77 · bullishproduct/pr
BridgeBio downgraded at Raymond James on LOE for Pfizer’s Vyndamax
Seeking Alpha33 · bearishanalyst
Citi Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn’t a Slam Dunk
Yahoo Top47 · neutralanalyst
Evercore ISI Retains an “Outperform Rating” on BridgeBio Pharma, Inc. (BBIO)
Yahoo Finance61 · neutralanalyst
BridgeBio Pharma Q1 Earnings Call Highlights
Yahoo Top53 · neutralearnings